Vir Biotechnology VIR Balance Sheet

Income Statement

Quarter End	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	1.95B	2.89B	2.62B	2.7B	2.8B	2.67B	2.24B	2.04B
Total Current Assets	1.56B	2.57B	2.29B	2.41B	2.52B	2.36B	1.95B	1.77B
Cash and Equivalents	347.82M	812.36M	1.51B	963.74M	848.63M	824.91M	666.95M	452.1M
Total Non-Current Assets	434.28M	385.16M	415.86M	382.58M	388.62M	411.06M	401.67M	375.03M
Total Liabilities	522.42M	886.12M	666.98M	546.12M	724.13M	695.14M	433.67M	369.81M
Total Current Liabilities	341.24M	702.36M	477.87M	308.2M	511.03M	485.29M	225.62M	165.05M
Total Non-Current Liabilities	181.18M	183.75M	189.11M	237.91M	213.1M	209.85M	208.04M	204.76M
Common Equity	13k	13k	13k	13k	13k	13k	13k	13k
Retained Earnings	-138.6M	380.02M	303.53M	478.84M	377.24M	236.34M	41.56M	-121.85M

Year End December 30 2023	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	251.57M	191.6M	512.07M	918.76M	1.95B	2.8B	1.92B
Total Current Assets	192.35M	117.78M	403M	772.37M	1.56B	2.52B	1.59B
Cash and Equivalents	187.92M	47.6M	109.34M	436.58M	347.82M	848.63M	241.58M
Total Non-Current Assets	-68.92M	-179.18M	423.94M	716.85M	1.43B	2.08B	1.59B
Total Liabilities	27.96M	61.64M	88.13M	201.91M	522.42M	724.13M	328.82M
Total Current Liabilities	12.44M	39.91M	59.21M	99.06M	341.24M	511.03M	175.41M
Total Non-Current Liabilities	15.52M	21.73M	29.82M	102.85M	181.18M	213.1M	153.42M
Total Equity	-68.92M	-179.18M	423.94M	716.85M	1.43B	2.08B	1.59B
Common Equity	3k	4k	11k	13k	13k	13k	13k
Retained Earnings	-77.95M	-193.84M	-368.52M	-667.18M	-138.6M	377.24M	-237.82M